Skip to main navigation Skip to search Skip to main content

The impact of individual Cognitive Stimulation Therapy (iCST) on cognition, quality of life, caregiver health, and family relationships in dementia: A randomized controlled trial

  • Martin Orrell
  • , Lauren Yates
  • , Phuong Leung
  • , Sujin Kang
  • , Zoe Hoare
  • , Christopher Whitaker
  • , Alistair Burns
  • , Martin Knapp
  • , Iracema Leroi
  • , Esme Moniz-Cook
  • , Stephen Pearson
  • , Stephen Simpson
  • , Aimee Spector
  • , Stephen Roberts
  • , Ian Russell
  • , Hugo de Waal
  • , Robert Woods
  • , Vasiliki Orgeta
    • University of Nottingham
    • University College London
    • Manchester Academic Health Sciences Centre
    • London School of Economics
    • University of Hull
    • Devon Partnership NHS Trust, Devon
    • Dorset Healthcare University NHS Foundation Trust, Dorset
    • Lincolnshire Partnership NHS Foundation Trust, Lincoln
    • Swansea University
    • Norfolk & Suffolk NHS Foundation Trust

    Research output: Contribution to journalArticlepeer-review

    333 Downloads (Pure)

    Abstract

    Background
    Cognitive Stimulation Therapy (CST) is a well-established group psychosocial intervention for people with dementia. There is evidence that homebased programmes of cognitive stimulation delivered by family caregivers may
    benefit both the person and the caregiver. However, no previous studies have
    evaluated caregiver-delivered CST. This study aimed to evaluate the effectiveness of a home-based, caregiver-led individual Cognitive Stimulation Therapy (iCST) program in (i) improving cognition and quality of life (QoL) for the person with dementia and (ii) mental and physical health (wellbeing) for the caregiver.
    Methods and Findings
    A single-blind, pragmatic randomized trial (RCT) at eight study sites across the UK. The intervention and blinded assessment of outcomes were conducted in
    participants’ homes. 356 people with mild to moderate dementia and their caregivers recruited from memory services, and community mental health teams. Participants were randomly assigned to iCST (75, 30 minute sessions) or treatment as usual (TAU) control over 25 weeks. iCST sessions consisted of themed activities designed to be mentally stimulating and enjoyable. Caregivers delivering iCST received training and support from an unblind researcher.
    Primary outcomes were cognition (Alzheimer’s Disease Assessment Scale –
    cognitive [ADAS-Cog]) and self-reported quality of life (QoL) (Quality of Life
    Alzheimer’s Disease [QoL-AD]) for the person with dementia, and general health
    status (Short Form-12 [SF-12]) for the caregiver. Secondary outcomes included:
    quality of the caregiving relationship from the perspectives of the person and of the caregiver (Quality of the Carer Patient Relationships Scale), and health-related QoL (EQ5D) for the caregiver.
    Original languageEnglish
    JournalPLoS Medicine
    DOIs
    Publication statusPublished - 28 Mar 2017

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'The impact of individual Cognitive Stimulation Therapy (iCST) on cognition, quality of life, caregiver health, and family relationships in dementia: A randomized controlled trial'. Together they form a unique fingerprint.

    Cite this